NCT05491343Unknown4 期
Management of Uterine Arteriovenous Malformation- a Comparison of 2 Management Possibilities- Observation vs. Progesterone Treatment/ a Randomized Control Trial
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 入组人数
- 28
- 主要终点
- AVM regression
研究概览
简要总结
A randomized trial which compares conservative management to progesterone based treatment for arteriovenous malformation
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •women between age of 18 to 50, diagnosed with AVM
- •hemodynamically stable at clinical presentation
排除标准
- •unstable patients
- •contraindication to treatment
- •US examination not in the US department
研究组 & 干预措施
Progesterone treatment
Experimental
干预措施: MedroxyPROGESTERone Injection [Depo-Provera] (Drug)
Progesterone treatment
Experimental
干预措施: Other (Device)
结局指标
主要结局
AVM regression
时间窗: 3 weeks
The time from diagnosis to regression
次要结局
未报告次要终点
研究者
Etty Spiegel
Dr.
HaEmek Medical Center, Israel
相似试验
尚未招募
1 期
Ttt of AdenomyosisAdenomyosisNCT06719934Al-Azhar University100
已完成
不适用
Fertility After Diagnosis and Management of Acquired Uterine Arteriovenous MalformationArteriovenous MalformationsNCT03656211Rennes University Hospital15
招募中
不适用
Simplified Conservative Measures in Managing Morbidly Adherent Placenta in Beni-Suef UniversityPlacenta AccretaNCT06465836Nesreen Abdel Fattah Abdullah Shehata172
Unknown
2 期
Clinical Trial of Uterine Artery Embolization for Uterine LeiomyomaLeiomyomaNCT00821275Sun Yat-sen University900
进行中（未招募）
不适用
Clinical effect of antithrombin concentrate treatment on uterine blood flow and the amount of Atenativ needed to maintain a normal antithrombin level during two weeks in early and severe preeclampsiaEUCTR2012-005770-57-SEdepartment of OBstetrics, Sahlgrenska university hospital